Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;21(1):20-26.
doi: 10.5114/pm.2022.113524. Epub 2022 Feb 10.

Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial

Walid E Mohammed  1 , Mustafa M Abbas  1 , Ibrahim A Abdelazim  1   2 , Mohammed M Salman  1
Affiliations

Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial

Walid E Mohammed et al. Prz Menopauzalny. 2022 Mar.

Abstract

Introduction: To evaluate sildenafil citrate as an adjuvant to clomiphene citrate (CC) for ovulation induction (OI) in women with polycystic ovary syndrome (PCOS).

Material and methods: A total of 595 infertile PCOS women were randomly assigned into either clomiphene/sildenafil (C/S) group or CC group. Transvaginal (TVS)-Doppler studies were done for participants when the dominant follicle reach 16 mm, to measure the resistance index, pulsatility index, and maximum velocity of sub-endometrial, uterine, and ovarian vessels. Participants were examined using TVS on the 21st day of the cycle to detect ovulation or, after a positive pregnancy test, for documentation of pregnancy. Participants with negative pregnancy tests were given 2 months' rest without OI, followed by crossover of OI medication between the 2 studied groups. The crossover results were assessed by TVS, TVS-Doppler, and pregnancy test.

Results: The endometrial thickness was significantly higher among the C/S than the CC group during the first 3 months (9.6 ±1.2 vs. 8.7 ±1.0 mm, respectively, p = 0.003) and after crossover of OI (9.1 ±1.3 vs. 8.2 ±1.0 mm, respectively, p = 0.007).The chemical and clinical pregnancy rates were significantly higher among the C/S compared to the CC group (39.8% and 36.6% vs. 25% and 18.98%, respectively) (p = 0.01 and 0.001, respectively) during the first 3 months and after crossover of OI (36.6% and 33.1% vs. 23.8% and 20.6%, respectively) (p = 0.02 and 0.01, respectively).

Conclusions: SC as an adjuvant to CC for OI in PCOS women increases the chemical and clinical pregnancy rates. It also improves the endometrial thickness and ovulation rate through improved endometrial and ovarian Doppler indices.

Keywords: PCOS; clomiphene citrate; induction of ovulation; sildenafil citrate.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Fig. 1
Fig. 1
The mean resistance index of the 2 studied groups in the first 3 months
Fig. 2
Fig. 2
The mean pulsatility index of the 2 studied groups in the first 3 months
Fig. 3
Fig. 3
The mean time-averaged maximum velocity of the 2 studied groups in the first 3 month
Fig. 4
Fig. 4
The mean resistance index of the 2 studied groups after crossover of ovulation induction medications
Fig. 5
Fig. 5
The mean pulsatility index of the 2 studied groups after crossover of ovulation induction medications
Fig. 6
Fig. 6
The mean time-averaged maximum velocity of the 2 studied groups after crossover of ovulation induction medications
See this image and copyright information in PMC

References

    1. Weiss NS, van Vliet MN, Limpens J, et al. . Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis. Hum Reprod 2017; 32: 1009-1018. - PubMed
    1. Fauser BC, Tarlatzis BC, Rebar RW, et al. . Consensus on women’s health aspects of Polycystic Ovary Syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97: 28-38.e25. - PubMed
    1. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Clomiphene, and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 2009; (4): CD002249. - PubMed
    1. Balen AH. Ovulation induction in the management of anovulatory Polycystic Ovary Syndrome. Mol Cell Endocrinol 2013; 373: 77-82. - PubMed
    1. Van Santbrink EJ, Fauser BC. Ovulation induction in normogonadotropic anovulation (PCOS) Best Pract Res. Clin Endocrinol Metab 2006; 20: 261-70. - PubMed